2024 annual financial data
Immunocore Holdings 2024 Operating margin
Immunocore Holdings 2024 operating margin with verified reported values.
Direct answer
Operating margin was -22.7%.
Operating income was -56,280,019 USD and net income was -40,805,230 USD.
Operating cash flow was 26,061,000 USD.
Get free Immunocore Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 247,983,620 USD
- Operating income
- -56,280,019 USD
- Net income
- -40,805,230 USD
- Operating cash flow
- 26,061,000 USD